JPH0545567B2 - - Google Patents
Info
- Publication number
- JPH0545567B2 JPH0545567B2 JP59073506A JP7350684A JPH0545567B2 JP H0545567 B2 JPH0545567 B2 JP H0545567B2 JP 59073506 A JP59073506 A JP 59073506A JP 7350684 A JP7350684 A JP 7350684A JP H0545567 B2 JPH0545567 B2 JP H0545567B2
- Authority
- JP
- Japan
- Prior art keywords
- bath
- present
- weakly acidic
- additives
- additive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000654 additive Substances 0.000 claims description 31
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 16
- 230000002378 acidificating effect Effects 0.000 claims description 15
- 230000000996 additive effect Effects 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 13
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 8
- 239000001384 succinic acid Substances 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 claims description 4
- 239000000341 volatile oil Substances 0.000 claims description 4
- 244000178870 Lavandula angustifolia Species 0.000 claims description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 2
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 2
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000001102 lavandula vera Substances 0.000 claims description 2
- 235000018219 lavender Nutrition 0.000 claims description 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 description 17
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 14
- 230000017531 blood circulation Effects 0.000 description 7
- 239000001569 carbon dioxide Substances 0.000 description 7
- 229910002092 carbon dioxide Inorganic materials 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 239000007789 gas Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 206010016352 Feeling of relaxation Diseases 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 3
- 238000003287 bathing Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000001931 thermography Methods 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000010446 mirabilite Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q13/00—Formulations or additives for perfume preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Description
本発明は新規な弱酸性入浴剤、更に詳細には、
炭酸水素ナトリウムとコハク酸を含有し、使用時
の浴湯PHが弱酸性を呈する入浴剤に特定の芳香薬
剤を配合することにより、血行保進効果およびび
リラツクス感・疲労回復効果を高めた弱酸性入浴
剤に関する。
入浴剤は一般に芒硝、硼砂、イオウ、食塩、炭
酸塩等の無機塩類混合物に香料、着色料、植物エ
キス、有機酸等を配合したもので、浴湯に香り、
色調を与えたり、皮膚面に適度な刺激を与えるこ
とにより血液の循環を活性にし、疲労回復、新陳
代謝を増進させるものである。これらの浴用剤の
中で、炭酸塩と酸を組合せた発泡性入浴剤があ
り、これは浴湯中に炭酸ガスな気泡を発生させ
て、リラツクス感や爽快感を高め、入浴を楽しく
する効果を有する。
しかしながら、従来の発泡性入浴剤は、中性な
いしは弱アルカリ性であつて、発生した炭酸ガス
のほとんど全ては水中に溶解せず、空気中に揮散
してしまうので、この炭酸ガスな気泡は単に感覚
的な機械的作用を奏するのみであつた。
そこで、本発明者は、種々研究を行い、炭酸水
素ナトリウムとコハク酸を含有し、浴湯のPHが弱
酸性を呈する入浴剤とすることにより、炭酸ガス
を浴液中に留め、血行を促進し、湯冷めを惹起し
ない弱酸性入浴剤を開発した。更に今般、本発明
者は、これに特定の芳香薬剤を配合すると血行促
進効果と覚醒若しくは催眠、色欲抑制若しくは促
進、不安解消等の効果が相乗的に改良され、リラ
ツクス感及び疲労回復効果が高められることを見
出し、本発明を完成した。
すなわち、本発明者は、炭酸水素ナトリウムと
コハク酸を含有し、浴湯に溶解した直後のPHが４
〜７（0.01重量％水溶液）の弱酸性入浴剤におい
て、ローズマリー精油、ラベンダー精油およびα
−ピネンから選ばれる芳香薬剤の１種または２種
以上を配合したことを特徴とする弱酸性入浴剤を
提供するものである。
本発明弱酸性入浴剤の炭酸水素ナトリウムとコ
ハク酸の配合量は、入浴剤を浴湯に加えたとき浴
湯が弱酸性を呈するような比率、すなわち入浴剤
の0.01重量％水溶液がPH４〜７、特に好ましくは
PH6.0〜6.7になるようにすることが必要である。
PHが４より低いと肌への刺激が強いと共に風呂釜
等をいためる惧れがあり、またPHが７を超えると
本発明の効果が奏されない。
本発明の効果は、PHが酸性の場合には炭酸ガス
はCO2分子として存在して血流促進作用を示す
が、PHがアルカリ性側では炭酸ガスはCO3 2-イオ
ンあるいはHCO3 -イオンとして存在するため当
該効果は全く見られないという原理に基くもので
ある。
斯かる条件を具備するための炭酸水素ナトリウ
ムとコハク酸の配合量は全組成に対し、炭酸水素
ナトリウムは５〜80重量％、特に10〜50％、コハ
ク酸は10〜80％、特に15〜50％が好ましい。
また、芳香薬剤は、広い範囲の量で配合できる
が、一般には全組成に対し0.001〜10％、特に
0.01〜２％が好ましい。
更に、本発明入浴剤には、一般に配合されてい
る、香料、色素、あるいはビタミン類、温泉の有
効成分、蛋白分解酵素、海草エキス、アルギン酸
ナトリウム、ラノリン、シリコン、生薬あるいは
その他の抽出エキス等を配合して、効果を一層高
めることができる。
本発明の弱酸性入浴剤は、粉末、顆部、結晶、
錠剤等、特に好ましくは錠剤の形にすることがで
き、これらの製剤化のために、必要に応じて賦形
剤、結合剤、崩壊剤、滑沢剤等を添加することも
できる。
叙上の如く、本発明の弱酸性入浴剤はPHが人の
肌と大略同一であるので肌に好影響を与える。し
かも浴湯に投ずるとき発生する炭酸ガスは、アル
カリ性ではイオンとして存在するため血流促進効
果はないが、本発明の如く酸性領域ではCO2分子
として存在して肌の血行を促進する優れた効果を
奏する。
次に実施例を挙げて説明する。
実施例 １
第１表に示す組成の入浴剤を調製し、各入浴剤
を0.01％水溶液になるように浴湯に投入し、パネ
ラー30名に１ヶ月間常法に従つて使用してもら
い、入浴剤としての全体評価（総合的な使用感）、
リラツクス感および疲労回復効果を調べた。
The present invention provides a novel weakly acidic bath additive, more specifically,
A bath additive that contains sodium bicarbonate and succinic acid and has a slightly acidic bath water pH when used, with a specific aromatic agent added to it to improve blood circulation and improve the effect of relaxing and recovering from fatigue. Regarding acidic bath additives. Bath additives are generally a mixture of inorganic salts such as mirabilite, borax, sulfur, salt, carbonate, etc., combined with fragrances, colorants, plant extracts, organic acids, etc., and add fragrance to the bath water.
By adding color and moderate stimulation to the skin surface, it activates blood circulation, recovers from fatigue, and improves metabolism. Among these bath additives, there are effervescent bath additives that combine carbonate and acid, which generate carbon dioxide gas bubbles in the bath water, increasing the feeling of relaxation and refreshment, and making bathing more enjoyable. has. However, conventional foaming bath additives are neutral or slightly alkaline, and almost all of the carbon dioxide gas generated does not dissolve in the water and evaporates into the air, so these carbon dioxide bubbles are simply a sensation. It had only a mechanical effect. Therefore, the present inventor conducted various research and created a bath additive that contains sodium hydrogen carbonate and succinic acid and has a slightly acidic PH of the bath water, thereby retaining carbon dioxide gas in the bath liquid and promoting blood circulation. We have developed a weakly acidic bath additive that does not cause the bath to feel cold. Furthermore, the present inventor has recently found that when a specific aromatic drug is added to this, the effects of promoting blood circulation, awakening or hypnosis, suppressing or promoting lust, relieving anxiety, etc. are synergistically improved, and the feeling of relaxation and fatigue recovery effect are enhanced. The present invention was completed based on this discovery. That is, the present inventor has developed a method that contains sodium hydrogen carbonate and succinic acid, and has a pH of 4 immediately after being dissolved in bath water.
~7 (0.01% by weight aqueous solution) weakly acidic bath additives containing rosemary essential oil, lavender essential oil and α
- Provides a weakly acidic bath additive characterized by containing one or more aromatic agents selected from pinene. The blending amounts of sodium bicarbonate and succinic acid in the weakly acidic bath additives of the present invention are such that when the bath additives are added to bath water, the bath water exhibits weak acidity, i.e., a 0.01% by weight aqueous solution of the bath additives has a pH of 4 to 7. , particularly preferably
It is necessary to adjust the pH to 6.0 to 6.7.
If the pH is lower than 4, there is a risk of strong skin irritation and damage to the bathtub, etc. If the pH is higher than 7, the effects of the present invention will not be achieved. The effect of the present invention is that when the pH is acidic, carbon dioxide gas exists as CO 2 molecules and exhibits a blood flow promoting effect, but when the pH is alkaline, carbon dioxide gas exists as CO 3 2- ions or HCO 3 - ions. This is based on the principle that the effect is not observed at all because the To meet such conditions, the amount of sodium hydrogen carbonate and succinic acid to be blended is 5 to 80% by weight, especially 10 to 50%, and 10 to 80%, especially 15 to 50%, by weight of sodium hydrogen carbonate, based on the total composition. 50% is preferred. Fragrance agents can be added in a wide range of amounts, but generally 0.001 to 10% of the total composition, especially
0.01-2% is preferred. Furthermore, the bath additives of the present invention may contain fragrances, pigments, vitamins, hot spring active ingredients, proteolytic enzymes, seaweed extracts, sodium alginate, lanolin, silicone, herbal medicines, or other extracted extracts. They can be combined to further enhance the effect. The weakly acidic bath additives of the present invention include powder, granules, crystals,
It can be made into tablets, particularly preferably in the form of tablets, and excipients, binders, disintegrants, lubricants, etc. can be added as necessary to form these formulations. As mentioned above, the weakly acidic bath additive of the present invention has a pH that is approximately the same as that of human skin, and therefore has a favorable effect on the skin. Moreover, the carbon dioxide gas generated when pouring into bath water exists as ions in alkaline conditions and has no effect of promoting blood flow, but in acidic conditions as in the present invention, it exists as CO 2 molecules and has an excellent effect of promoting blood circulation in the skin. play. Next, an example will be given and explained. Example 1 Bath additives with the compositions shown in Table 1 were prepared, each bath additive was added to bath water to make a 0.01% aqueous solution, and 30 panelists were asked to use it in the usual manner for one month. Overall evaluation as a bath additive (overall feeling of use),
The feeling of relaxation and fatigue recovery effects were investigated.
【表】 その結果は第２表のとおりである。【table】 The results are shown in Table 2.
【表】
実施例 ２
第３表に示す組成の入浴剤を調製し、各入浴剤
を0.01％水溶液になるように浴湯に投入し、パネ
ラー20名に１ヶ月間常法に従つて使用してもら
い、入浴剤としての全体評価（総合的な使用感）、
リラツクス感および疲労回復効果を調べた。
結果は第４表に示した。評価は５段階評価（よ
い：５、ややよい：４、どちらともいえない：
３、ややよくない：２、よくない：１）の平均点
を表示した。[Table] Example 2 Bath additives with the compositions shown in Table 3 were prepared, each bath additive was added to bath water to make a 0.01% aqueous solution, and 20 panelists used it in the usual manner for one month. Overall evaluation of the bath salts (overall feeling of use)
The feeling of relaxation and fatigue recovery effects were investigated. The results are shown in Table 4. Evaluation is on a 5-point scale (good: 5, fair: 4, unsatisfactory:
The average score is shown as 3, somewhat poor: 2, and poor: 1).
【表】【table】
【表】
比較例５は本発明品３よりα−ピネンを除いた
もの、比較例６は本発明品よりコハク酸が少なく
重炭酸水素ナトリウムが多いため、弱酸性とはな
つていないものである。比較例はいずれも本発明
品と比べ効果が劣つていることが第４表の結果か
ら明らかである。
実施例 ３
本発明入浴剤の浴用効果について以下の如くし
て評価した。
（方法）
被験者６名を対象として、本発明品３、比較品
５および比較品６の浴剤添加浴に10分間入浴さ
せ、入浴前後の皮膚表面温をサーモグラフイーを
用いて比較した。湯温は40℃とし室温は27℃、浴
剤は1000倍に希釈して用いた。
（結果）
測定結果は、第５表に示した。本表から明らか
なように、本発明品は優れた保温効果を示すこと
がわかる。[Table] Comparative Example 5 is the product of the present invention with α-pinene removed, and Comparative Example 6 is less weakly acidic than the product of the present invention because it contains less succinic acid and more sodium bicarbonate than the product of the present invention. . It is clear from the results in Table 4 that all of the comparative examples have inferior effects compared to the products of the present invention. Example 3 The bath effect of the bath additive of the present invention was evaluated as follows. (Method) Six subjects were allowed to take a bath for 10 minutes in the bath additive baths of Inventive Product 3, Comparative Product 5, and Comparative Product 6, and their skin surface temperatures before and after bathing were compared using thermography. The water temperature was 40°C, the room temperature was 27°C, and the bath additives were diluted 1000 times. (Results) The measurement results are shown in Table 5. As is clear from this table, it can be seen that the products of the present invention exhibit excellent heat retention effects.
【表】
示す。
実施例 ４
本発明の入浴剤の浴用効果について以下の如く
して評価した。
（方法）
被験者４名を対象として、本発明品１、本発明
品２、比較品７および比較品８の浴剤添加浴に10
分間入浴させ、入浴前後の皮膚表面温をサーモグ
ラフイーを用いて比較した。湯温は40℃とし、室
温は27℃、浴剤は1000倍に希釈して用いた（150
ｇ／）。[Table] Shown.
Example 4 The bath effect of the bath additive of the present invention was evaluated as follows. (Method) For 4 subjects, 10% of bath additives were added to the bath additive baths of Inventive Product 1, Inventive Product 2, Comparative Product 7, and Comparative Product 8.
The subjects were allowed to take a bath for minutes, and the skin surface temperatures before and after bathing were compared using thermography. The water temperature was 40°C, the room temperature was 27°C, and the bath additives were diluted 1000 times (150
g/).
【表】
（結果）
測定結果は第７表に示した。本表から明らかな
ように、本発明品は優れた保温効果を示すことが
わかる。[Table] (Results) The measurement results are shown in Table 7. As is clear from this table, it can be seen that the products of the present invention exhibit excellent heat retention effects.
【表】
示す。
[Table] Shown.
Claims (1)
湯に溶解した直後のPHが４〜７（0.01重量％水溶
液）の弱酸性入浴剤において、ローズマリー精
油、ラベンダー精油およびα−ピネンから選ばれ
る芳香薬剤の１種または２種以上を配合したこと
を特徴とする弱酸性入浴剤。1. A weakly acidic bath additive containing sodium bicarbonate and succinic acid and having a pH of 4 to 7 (0.01% by weight aqueous solution) immediately after being dissolved in bath water, with an aroma selected from rosemary essential oil, lavender essential oil, and α-pinene. A weakly acidic bath additive characterized by containing one or more types of drugs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7350684A JPS60215617A (en) | 1984-04-12 | 1984-04-12 | Weak-acidity bath preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7350684A JPS60215617A (en) | 1984-04-12 | 1984-04-12 | Weak-acidity bath preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60215617A JPS60215617A (en) | 1985-10-29 |
| JPH0545567B2 true JPH0545567B2 (en) | 1993-07-09 |
Family
ID=13520198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7350684A Granted JPS60215617A (en) | 1984-04-12 | 1984-04-12 | Weak-acidity bath preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60215617A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001311228A (en) * | 2000-04-27 | 2001-11-09 | Mitsubishi Rayon Co Ltd | Protective material for joint and protective method |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0816050B2 (en) * | 1988-04-01 | 1996-02-21 | 花王株式会社 | Bath additive |
| KR19990080676A (en) * | 1998-04-20 | 1999-11-15 | 서경배 | Natural fragrance-containing cosmetic composition that has a soothing effect on muscle fatigue |
| JP2002205932A (en) * | 2001-01-11 | 2002-07-23 | Pola Chem Ind Inc | Perfume composition for awakening and cosmetic product for aesthetic treatment containing the same |
| JP2002308724A (en) * | 2001-03-29 | 2002-10-23 | Council Scient Ind Res | Safe, eco-friendly, health rpotective herbal color and aroma useful for cosmaceutical application |
| JP6081770B2 (en) * | 2012-05-28 | 2017-02-15 | 株式会社ホットアルバム炭酸泉タブレット | Microbubble mixed water manufacturing method and microbubble mixed water manufacturing device |
| TWI627972B (en) * | 2013-05-10 | 2018-07-01 | 花王股份有限公司 | Bath preparation composition |
| JP6576194B2 (en) * | 2015-09-30 | 2019-09-18 | アース製薬株式会社 | Effervescent compression molding bath |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5970609A (en) * | 1982-10-14 | 1984-04-21 | Kao Corp | Weakly acidic bathing agent |
-
1984
- 1984-04-12 JP JP7350684A patent/JPS60215617A/en active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5970609A (en) * | 1982-10-14 | 1984-04-21 | Kao Corp | Weakly acidic bathing agent |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001311228A (en) * | 2000-04-27 | 2001-11-09 | Mitsubishi Rayon Co Ltd | Protective material for joint and protective method |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60215617A (en) | 1985-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS609009B2 (en) | Foaming bath agent | |
| JPH0545567B2 (en) | ||
| JP2622574B2 (en) | Bath additive | |
| JPS647965B2 (en) | ||
| JPS5970609A (en) | Weakly acidic bathing agent | |
| KR0163501B1 (en) | Bathing composition | |
| JPH0427206B2 (en) | ||
| JPH1025240A (en) | Bathing agent | |
| JPS61280417A (en) | Weakly acidic bath agent | |
| JPH09291024A (en) | Bathing agent composition | |
| JPH0334919A (en) | Bathing agent | |
| JPH056524B2 (en) | ||
| JPS60185710A (en) | Bath preparation of weak acidity | |
| JPH0236569B2 (en) | ||
| JPS6277312A (en) | Foaming bath agent | |
| JPS60215618A (en) | Weak-acidity bath preparation | |
| JPH0769862A (en) | Bathing agent composition | |
| JP3457395B2 (en) | Bath composition | |
| KR20070040980A (en) | Preparations for face and body washing having foarming properties | |
| JPH0113A (en) | Bath preparation | |
| JPS60215613A (en) | Weak-acidity bath preparation | |
| JPH0363217A (en) | Bath agent | |
| JPH0912445A (en) | Bathing agent composition | |
| JPS60218313A (en) | Weakly acidic bath agent | |
| JPS60215615A (en) | Weak-acidity bath preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |